close

  • home Home

  • linked_services Solutions keyboard_arrow_down

    • biotech Core Disciplines keyboard_arrow_down

      • View All
      • Quality Control
      • EQA
      • Chemistry
      • Immunoassay
      • Molecular
      • Point of Care
      • Toxicology
      • Food Diagnostics
      • BioSciences
      • BioReagents
      • Veterinary

    • neurology Disease Areas keyboard_arrow_down

      • View All
      • Acute Kidney Injury
      • Alzheimer's Disease
      • Chronic Kidney Disease
      • Chronic Lung Infection
      • Colorectal Cancer
      • Familial Hypercholesterolemia
      • Gastrointestinal
      • Hyperinflammation
      • Immunodeficiency
      • Neurovascular Dysfunction
      • Pancreatic Cancer
      • Urinary Tract Infection
      • Female Bladder Cancer Array
      • Acute Respiratory Distress Syndrome (ARDS)

    • store Online Store

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

    • Our Story
    • Our Vision
    • Our Team
    • Partners & Sponsorships
    • Charity Partners
    • Collaborators
    • Careers

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu
Randox Health search

Why use Biochip?

n the UK, there are million consultations per day in primary care. Gastrointestinal (GI) complaints account for up to 10% of these consultations. A further 50% of these consultations are for upper GI symptoms such as dyspepsia (epigastric pain/indigestion).

Results from a systematic review:

Around 80% of patients with dyspepsia had a normal endoscopy. These patients likely had functional dyspepsia (no pathology or obvious cause for symptoms).

*Used in conjunction with a Pepsinogen I/II Ratio Calculation

Biochip Markers
Gastrin-17Pepsinogen IPepsinogen II

Application

Aiding clinicians with fast-track stratification to identify the following:

  • Corpus - Limited Atrophic Gastritis
  • Increase Risk of Stomach Cancer
  • H. Pylori Infection
  • Pernicious Anaemia
  • High Stomach Acid
  • Coeliac Disease
  • Gastritis
  • Atrophic Gastritis
  • Inflammatory Bowel Disease
  • Lack of Stomach Acid
  • Autoimmune Atrophic Gastritis
  • Antrum-Limited Atrophic Gastritis

Significantly reducing and eliminating the need for:

local_hospital

Hospital Referrals

detector

Unnecessary Scans

endocrinology

Endoscopy Procedures

The Evidence MultiSTAT

Evidence MultiSTAT

The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.

Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.

With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.

MultiSTAT Cartridge

The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.

The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.

No other components are required.

Get in touch to discover more

To find out more about the Evidence MultiSTAT or to discuss arranging a demo, enquire now.

Make an Enquiry mail
download Download brochure
Bladder Cancer (BCa)
Prostate Cancer (PCa)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Male & Female Hormone